1 Adachi M, konno S, Gonokami Y, et al. Studies on biphasic animal model of asthma:lymphocytes and eosinophils. Nippon KyobuS hikkai Gakkai Zasshi, 1993, 31 (Suppl):185
2 Obata H, Tao Y, Kido M, et al. Guinea pig model of immunologic asthma induced by inhalation of trinellitic anhydride. Am Tev Tespir Dis, 1992, 146(6):1553
3 Nakagawa N, Obata T, Kobayashi T, et al. Effect of a peptide leukotriene receptor antagonist, ONO 1078, on guinea pig models of asthma. Eur J Pharmacol, 1993, 235 (2 ～ 3):211
4 Chabot-Fletcher MC, Underwood DC, Breton JJ, et al. Pharmacological character ization of SB202235, apotent and seletive 5-lipoxygenase inhibitor:effects in models of allergic asthma. J Pharmacol Exp Ther, 1995, 273(3):1147
5 Itoh K, Takahashi E, MUkaiyama O, et al. Effects of a thromoboxane synthase inhibitor (CS 518)on the eoxionphil-dependent late asthmatic response and airway hyperre sporsiveness in guine a pig. Int Arch Allergy Immunol, 1996, 109(1):79
6 Matsumoto T, Ashida Y, Tsukuda R. Pharma cological modulation of immediate and late airway response and leukocy teinfiltr ation in the guinea pig. J Pharmacol Exp Ther, 1994, 269(3):1276
7 Songur N, Fujimura M, Izuhashi K, et al. Involv emen t of thromboxane A 2 in propranolol-induced broncho constriction after allergic bronchoconst riction in guinea pigs. Am J Respir Cara Med 1994, 149(6):1488
8 Hu H, Takata M, Kusakawa I, et al. Intratracheal adminisration of phosphodieste rase Ⅲ inhibito rattenuates bronchoconst riction in cats:a preliminary report. Pediatr Pulmonol, 1995, 19(6):360
9 Sugasawa T, Imanishi N, Morooka S. Effect of the selective PAR antagonist SM 10661 on an asthmatic model. 2. Effect on antigen-induced dual asthmatic response and infiltration of leukocy tes into airwasys in actively sensitized conscious guinea pigs. Lipids, 1991, 26(12):1305
10 Arima M, Yukawa T, Makino S. Effect of YM 264 on the airway hyper responsivenss and the late asthmatic response in a guinea pig model of asthma. Chest, 1995, 108 (2):529
11 Lukacs NE, Strieter RM, Chensue SW, et al. Inte rleukin-4-dependent pulmonaryeo sinophil infiltration in a murine model of asthma. An J Respir Cell Mol Biol, 1994, 19(5):526
12 Foster PS, Hogan SP, Ramsay AJ, et al. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and Lung damage in a mouse asthma model. J Exp Med, 1996, 183(1):195
13 Nasert S, Millner M, Herz U, et al. Therapeutic interference with interferon-gamma (INF-g amma)and soluble IL-4 receptor (sIL-4RA)in allergic diseases. Behring Inst Mitt, 1995, (96):118
14 Mauser PJ, Pitman AM, Fernandez X, et al. Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med, 1995, 152(2):467
15 Itoh K, TaKahashi E, Mukaiyama O, et al. Relationship Between airway eosinophilia and airway hyper-responsiveness in a late asthmatic model of guinea pigs. Int Arch Allergy Immunol, 1996, 109(1):86
16 Gavett SH, O'Hearn DJ, Li X, et al. Interleukin 12 inhibits antigen-induced airw ay hyper responsiveness, inflammation, and The cytokine expression in mice. J Exp Med, 1995, 182(15):1527
17 Vignola AM, Chanez P, Campbell AM, et al. Mechanisms of bronchial hyper reactivity:Role of the epithelium. Rev Mal Respir, 1994, 11(2):141
18 Blyth DI, Pedrick MS, Savage TJ, et al. Lung inflammation and epithelial changes in a murine model of atopicasthma.Am J Respir Cell Mol Biol, 1996, 14(5):525
19 Savoie C, Plant M, Zwikker M, et al. Effect of dexme thasone on antigenguinea pigs. Am J Re spir Cell Mol Biol, 1995, 13(2):133 |
